BURDEN OF HEPATITIS C IN CENTRAL AND EASTERN EUROPEAN COUNTRIES
Author(s)
Zoltan Kalo, MD, PhD, Eötvös Loránd University, Budapest, Hungary; Lubov Krasnova, MD, PhD, First Sechenov State Medical University, Moscow, Russian Federation; Anush Perikhanyan, MPH, Yerevan State Medical University, and President, ISPOR Armenia Chapter, Yerevan, Armenia; Guenka Petrova, DSci, Medical University Sofia, Faculty of Pharmacy, and President, ISPOR Bulgaria Chapter, Sofia, Bulgaria; Elena Pyadushkina, PharmD, Russian Presidential Academy of National Economy and Public Administration, Moscow, Russian Federation
Presentation Documents
DESCRIPTION: The medical and economic burden of hepatitis C is more significant in lower income countries than in high income economies in Europe. This Forum will focus on introducing highly effective new medicines in this field, discussing better understanding of disease burden, and trade-offs between health, affordability and equity objectives. Speakers will aim to review existing information on the burden of hepatitis C in Central and Eastern European (CEE) countries and identify evidence gaps to facilitate informed policy decisions about new medicines.
Conference/Value in Health Info
2016-10, ISPOR Europe 2016, Vienna, Austria
Code
F4
Topic
Economic Evaluation, Organizational Practices